Impact, healthcare utilization and costs of travel-associated mosquito-borne diseases in international travellers: a prospective study
Journal of Travel Medicine · 2023
DOI: 10.1093/jtm/taad060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Travel Medicine, 2023. Verfasst von Yesim Tozan und 18 weiteren Autor:innen. Beteiligte Einrichtung: School of Global Public Health, New York University, New York, NY, United States. Hauptthemen laut MEDLINE: Chikungunya Fever, Vector Borne Diseases, Malaria, Falciparum, Dengue. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: NCEZID CDC HHS.
Abstract (Originalsprache)
Background
International travellers frequently acquire infectious diseases whilst travelling, yet relatively little is known about the impact and economic burden of these illnesses on travellers. We conducted a prospective exploratory costing study on adult returning travellers with falciparum malaria, dengue, chikungunya or Zika virus.
Methods
Patients were recruited in eight Travel and Tropical Medicine clinics between June 2016 and March 2020 upon travellers’ first contact with the health system in their country of residence. The patients were presented with a structured 52-question self-administered questionnaire after full recovery to collect information on patients’ healthcare utilization and out-of-pocket costs both in the destination and home country, and about income and other financial losses due to the illness.
Results
A total of 134 patients participated in the study (malaria, 66; dengue, 51; chikungunya, 8; Zika virus, 9; all fully recovered; median age 40; range 18–72 years). Prior to travelling, 42% of patients reported procuring medical evacuation insurance. Across the four illnesses, only 7% of patients were hospitalized abroad compared with 61% at home. Similarly, 15% sought ambulatory services whilst abroad compared with 61% at home. The average direct out-of-pocket hospitalization cost in the destination country (USD $2236; range: $108–$5160) was higher than the direct out-of-pocket ambulatory cost in the destination country (USD $327; range: $0–$1560), the direct out-of-pocket hospitalization cost at home (USD $35; range: $0–$120) and the direct out-of-pocket ambulatory costs at home (US$45; range: $0–$192). Respondents with dengue or malaria lost a median of USD $570 (Interquartile range [IQR] 240–1140) and USD $240 (IQR 0–600), respectively, due to their illness, whilst those with chikungunya and Zika virus lost a median of USD $2400 (IQR 1200–3600) and USD $1500 (IQR 510–2625), respectively.
Conclusion
Travellers often incur significant costs due to travel-acquired diseases. Further research into the economic impact of these diseases on travellers should be conducted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Global Public Health, New York University, New York, NY, United States.
- New York University Abu Dhabi, Abu Dhabi, United Arab Emirates.
- Unité Parasitologie et Entomologie, Département Microbiologie et Maladies Infectieuses, Institut de Recherche Biomédicale des Armées (IRBA), Marseille, France.
- Aix Marseille Univ, IRD, SSA, AP-HM, VITROME, Marseille, France.
- IHU Méditerranée Infection, Marseille, France.
- Center for Tropical and Travel Medicine, University of Amsterdam, Amsterdam, The Netherlands.
Förderung
- NCEZID CDC HHS
Zitieren
APA
Tozan, Y., Headley, T. Y., Javelle, E., Gautret, P., Grobusch, M., de Pijper, C., Asgeirsson, H., Chen, L. H., Bourque, D. L., Menéndez, M. D., Moro, L., Gobbi, F., Sánchez-Montalvá, A., Connor, B. A., Matteelli, A., Crosato, V., Huits, R., Libman, M., & Hamer, D. H. (2023). Impact, healthcare utilization and costs of travel-associated mosquito-borne diseases in international travellers: a prospective study. Journal of Travel Medicine. https://doi.org/10.1093/jtm/taad060
Vancouver
Tozan Y, Headley TY, Javelle E, Gautret P, Grobusch M, de Pijper C, et al. Impact, healthcare utilization and costs of travel-associated mosquito-borne diseases in international travellers: a prospective study. Journal of Travel Medicine. 2023. doi:10.1093/jtm/taad060
BibTeX
@article{Tozan2023,
author = {Tozan, Yesim and Headley, Tyler Y and Javelle, Emilie and Gautret, Philippe and Grobusch, Martin and de Pijper, Cornelis and Asgeirsson, Hilmir and Chen, Lin H and Bourque, Daniel L and Menéndez, Marta D and Moro, Lucia and Gobbi, Federico and Sánchez-Montalvá, Adrián and Connor, Bradley A and Matteelli, Alberto and Crosato, Verena and Huits, Ralph and Libman, Michael and Hamer, Davidson H},
title = {Impact, healthcare utilization and costs of travel-associated mosquito-borne diseases in international travellers: a prospective study},
journal = {Journal of Travel Medicine},
year = {2023},
doi = {10.1093/jtm/taad060}
}
EUVIMED